Repositioning Drugs for a Better Outcome. Nevakar is a specialty injectable pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.
Location: United States, New Jersey, Green Knoll
Employees: 51-200
Total raised: $135M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | H.I.G. Cap... | higcapital... |
| - | H.I.G. Bio... | higbio.com |
| - | H.I.G. Cap... | hig.com/ |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 17.06.2019 | Private Eq... | $50M | - |
| 30.11.2018 | - | $30M | - |
| 27.07.2016 | - | $55M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 30.11.2018 | Daily funding roundup - November 30th, 2018 | Lentesplus.com raised $5M; MondoBrain raised $13.3M; Nevakar raised $20M; UrbanClap raised $50M Lent... | vator.tv/n... |
| 30.11.2018 | Nevakar Completes $30M Financing | Nevakar Inc., a Bridgewater, New Jersey-based specialty pharmaceutical company developing multiple p... | finsmes.co... |
| 27.07.2016 | Nevakar Announces $55 Million Fundraising | Nevakar LLC, a privately-held specialty pharmaceutical company developing innovative products focuse... | citybizlis... |